Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Unlearn

Dr. Robert Lenz Joins Unlearn as Strategic Advisor
From Unlearn
Via Business Wire
Unlearn Appoints Its First Vice President of Product
From Unlearn
Via Business Wire
Unlearn Appoints Krates Ng as Chief Technology Officer
From Unlearn
Via Business Wire
Unlearn and remynd Partner on Alzheimer’s Study to Strengthen Confidence in Early Clinical Signals Using Digital Twins
From Unlearn
Via Business Wire
Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial
From Unlearn
Via Business Wire
Unlearn’s 2024 Achievements Drive Innovation in AI for Clinical Development
From Unlearn
Via Business Wire
Unlearn and APST Research Partner to Build High-Quality Dataset to Accelerate ALS Clinical Trials
From Unlearn
Via Business Wire
Unlearn Announces Leadership Transition to Accelerate Commercial Growth and AI Innovation
From Unlearn
Via Business Wire
Unlearn Presents Studies on AI-powered Clinical Trials with AbbVie and Johnson & Johnson Innovative Medicine at the Alzheimer's Association International Conference 2024
From Unlearn
Via Business Wire
Unlearn Publishes Peer-Reviewed Article Evidencing the Path to Applying AI-Powered Digital Twins in Healthcare
From Unlearn
Via Business Wire
Steven Herne Joins Unlearn’s Executive Team as Chief Commercial Officer
From Unlearn
Via Business Wire
Unlearn’s TwinRCT Solution Update Enhances Phase 2 Trial Decision-Making Power
From Unlearn
Via Business Wire
Introducing Unlearn’s TrialPioneer: A Free Tool for Exploring Innovative Clinical Trial Designs Using AI
From Unlearn
Via Business Wire
Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology
From Unlearn
Via Business Wire
Unlearn Appoints Arman Sabbaghi, Ph.D. as Head of Biostatistics Research
From Unlearn
Via Business Wire
Unlearn Appoints Alex Lang, Ph.D. as Vice President, Technology
From Unlearn
Via Business Wire
European Medicines Agency Qualifies Unlearn’s AI-powered Method for Running Smaller, Faster Clinical Trials
From Unlearn
Via Business Wire
Unlearn Receives Draft Qualification Opinion from European Medicines Agency for Using the PROCOVA™ Framework to Implement TwinRCTs™
From Unlearn
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.